Recent advances in Life Sciences | May 2018 Newsletter | MaxVal

Posted by

The article presents a base editing approach to expand the scope and efficiency of CRISPR mediated genome editing.

It highlights recent FDA approval for a trial involving Artificial Intelligence-powered insulin infusion device for diabetes management.

Leave a Reply

Your email address will not be published. Required fields are marked *